Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The role of transforming growth factor beta 2 (TGF-beta 2) in the pathogenesis of systemic sclerosis (SSc) was investigated by in situ hybridization of skin biopsies from six patients with SSc. Two patients with acute systemic lupus erythematosis (SLE), one with acute dermatomyositis (DM), and three healthy individuals were used as controls. TGF-beta 2 mRNA was found to be co-localized with pro alpha 1(I) collagen expression around dermal blood vessels in all patients with the inflammatory stage of SSc, whereas there was no expression of either gene in the dermis of patients in the fibrotic stage, the SLE patients or the normal controls. These findings provide evidence that TGF-beta 2 released by inflammatory cells around blood vessels may play a role in mediating the collagen gene disregulation in fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Varga, J., Rosenbloom, J., & Jimenez, S. A. (1987) · Biochemical Journal · doi:10.1042/bj2470597 · Cited by 591
Cited by
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Transforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E. (1992) · Nature · doi:10.1038/360361a0 · Cited by 974
Connective tissue growth factor: a mediator of TGF-β action on fibroblasts
Grotendorst, G. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00010-5 · Cited by 761
Frazier, K., Williams, S., Kothapalli, D., Klapper, H., & Grotendorst, G. R. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363389 · Cited by 757
Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Fujimoto, M., Grotendorst, G. R., & Takehara, K. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12345771 · Cited by 438
Yamamoto, T., Takagawa, S., Katayama, I., Yamazaki, K., Hamazaki, Y., Shinkai, H., & Nishioka, K. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00528.x · Cited by 432
Expression of transforming growth factor-β isoforms in human glomerular diseases
Yamamoto, T., Noble, N. A., Cohen, A. H., Nast, C. C., Hishida, A., Gold, L. I., & Border, W. A. (1996) · Kidney International · doi:10.1038/ki.1996.65 · Cited by 418
Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure
Wahl, S. M. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918135 · Cited by 407
Pathogenesis of fibrosis: role of TGF-β and CTGF
Ihn, H. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200211000-00009 · Cited by 354
Francois, V, Solloway, M., O'Neill, J. W., Emery, J., & Bier, E. (1994) · Genes & Development · doi:10.1101/gad.8.21.2602 · Cited by 308
“It is also noteworthy that procollagen expression is tightly linked to that of TGF-p (Nakatsukasa et al. 1990; Kulozik et al. 1990) and that TGF-p can induce procollagen gene expression (McAnulty et al. 1991; Ritzenthaler et al. 1993).”
BackgroundSato, S., Hasegawa, M., & Takehara, K. (2001) · Journal of Dermatological Science · doi:10.1016/s0923-1811(01)00128-1 · Cited by 297
Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Grotendorst, G. R., & Takehara, K. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12318465 · Cited by 277
Biology of Dermal Wound Repair
Clark, R. A. F. (1993) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30218-3 · Cited by 268
Kawakami, T., Ihn, H., Xu, W., Smith, E., LeRoy, C., & Trojanowska, M. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00073.x · Cited by 260
Zhang, Y., McCormick, L. L., Desai, S. R., Wu, C., & Gilliam, A. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.3088 · Cited by 256
Yamakage, A., Kikuchi, K., Smith, E. A., LeRoy, E. C., & Trojanowska, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1227 · Cited by 184
Vowels, B. R., Cassin, M., Boufal, M. H., Walsh, L. J., & Rook, A. H. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499907 · Cited by 183
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma
Pines, M., Snyder, D., Yarkoni, S., & Nagler, A. (2003) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(03)00151-4 · Cited by 173
“Elevated levels of TGF- were found in involved skin lesions of SSc patients [62,63], in murine models of sclerodermatous GvHD [64], and in the pathogenesis of graft vascular disease [65].”
BackgroundAntagonistic Effects of Interferon-γ and Interleukin-4 on Fibroblast Cultures.
Serpier, H., Gillery, P., Salmon-Ehr, V., Garnotel, R., Georges, N., Kalis, B., & Maquart, F.-X. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12319207 · Cited by 88
Bernard, M., Dieudé, M., Yang, B., Hamelin, K., Underwood, K., & Hébert, M.-J. (2014) · Autophagy · doi:10.4161/15548627.2014.981786 · Cited by 86
Metadata
- Authors
- Kulozik, M., Hogg, A., Lankat-Buttgereit, B., & Krieg, T.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-09-01
- Volume
- 86
- Issue
- 3
- Pages
- 917-922
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2000508527
- Cited by
- 217
- References
- 2
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.